Laddar...

Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic

BACKGROUND: DNA damage response (DDR) defects imply genomic instability and favor tumor progression but make the cells vulnerable to the pharmacological inhibition of the DNA repairing enzymes. Targeting cellular proteins like PARPs, which cooperate and complement molecular defects of the DDR proces...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Exp Clin Cancer Res
Huvudupphovsmän: Cerrato, Aniello, Morra, Francesco, Celetti, Angela
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5123312/
https://ncbi.nlm.nih.gov/pubmed/27884198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-016-0456-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!